Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Intensification of Methotrexate in Advanced NHL and B-ALL
NCT00005977Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Sep 2000
- Primary completion
- Mar 2004
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of methotrexate in non-Hodgkin lymphoma (NHL), B cell acute lymphoblastic leukemia (B-ALL), sponsored by Children's Oncology Group. Started Sep 2000; status: completed.
02
Drugs
methotrexate
03
Conditions
non-Hodgkin lymphoma (NHL)B cell acute lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on NCT00005977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005977.